Treatment OutcomeDrug Resistance, ViralStem Cell TransplantationGenetic TherapyPrognosisClinical Trials as TopicDisease Models, AnimalHIV InfectionsAntineoplastic AgentsOutcome Assessment (Health Care)ApoptosisSignal TransductionRetrospective StudiesPregnancy OutcomeFollow-Up StudiesAntitubercular AgentsProspective StudiesTime FactorsDirectly Observed TherapyCognitive TherapyRisk FactorsCohort StudiesOutcome and Process Assessment (Health Care)Treatment FailureSurvival AnalysisSeverity of Illness IndexCombined Modality TherapySurvival RatePredictive Value of TestsRecurrencePatient ComplianceTuberculosis, PulmonaryExtensively Drug-Resistant TuberculosisRandomized Controlled Trials as TopicPregnancyTuberculosis, Multidrug-ResistantMultivariate AnalysisSubstance-Related DisordersUnited StatesBuprenorphineQuality of LifeKaplan-Meier EstimateAge FactorsPsychotherapyLogistic ModelsOpioid-Related DisordersInfant, NewbornRisk AssessmentSubstance Abuse Treatment CentersAlcoholismForecastingDrug Therapy, CombinationNeoplasm StagingTuberculosisPatient SatisfactionAntineoplastic Combined Chemotherapy ProtocolsHospitals, Chronic DiseaseTemperancePsychiatric Status Rating ScalesReproducibility of ResultsLongitudinal StudiesRemission InductionPatient DropoutsImplosive TherapyCocaine-Related DisordersPostoperative ComplicationsRegression AnalysisDisease-Free SurvivalIncidenceDepressive Disorder, MajorGenotypeResearch DesignProportional Hazards ModelsMethadoneChi-Square DistributionSex FactorsDisease ProgressionRetreatmentResidential TreatmentAnalysis of VarianceBehavior TherapyAnti-Retroviral AgentsPatient SelectionMedication AdherencePilot ProjectsCoinfectionAnti-HIV AgentsNeoplasm Recurrence, LocalMotivationEthambutolPharmacogeneticsBiological MarkersPrecursor Cell Lymphoblastic Leukemia-LymphomaRegistriesRibavirinAcute DiseaseAntidepressive AgentsOpiate Substitution TreatmentQuestionnairesPrevalence